Ryan Specialty Holdings, Inc. (NYSE:RYAN) Shares Bought by Zurcher Kantonalbank Zurich Cantonalbank

Zurcher Kantonalbank Zurich Cantonalbank increased its stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 18.2% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 27,268 shares of the company’s stock after acquiring an additional 4,199 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Ryan Specialty were worth $1,750,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. State Street Corp increased its position in Ryan Specialty by 1.5% during the third quarter. State Street Corp now owns 3,273,093 shares of the company’s stock worth $217,301,000 after purchasing an additional 49,198 shares during the last quarter. Janus Henderson Group PLC increased its position in Ryan Specialty by 0.4% during the third quarter. Janus Henderson Group PLC now owns 3,148,916 shares of the company’s stock worth $209,058,000 after purchasing an additional 13,986 shares during the last quarter. Principal Financial Group Inc. increased its position in Ryan Specialty by 115.2% during the fourth quarter. Principal Financial Group Inc. now owns 1,833,209 shares of the company’s stock worth $117,619,000 after purchasing an additional 981,505 shares during the last quarter. Barclays PLC increased its position in Ryan Specialty by 1.1% during the third quarter. Barclays PLC now owns 1,641,743 shares of the company’s stock worth $108,994,000 after purchasing an additional 17,267 shares during the last quarter. Finally, Raymond James Financial Inc. acquired a new position in Ryan Specialty during the fourth quarter worth approximately $94,484,000. 84.82% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on RYAN shares. Morgan Stanley started coverage on shares of Ryan Specialty in a research report on Thursday, December 5th. They set an “overweight” rating and a $90.00 price target for the company. Royal Bank of Canada dropped their price target on shares of Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating for the company in a research report on Friday, February 21st. UBS Group boosted their price objective on shares of Ryan Specialty from $82.00 to $84.00 and gave the stock a “buy” rating in a research note on Wednesday, February 26th. Wells Fargo & Company boosted their price objective on shares of Ryan Specialty from $64.00 to $69.00 and gave the stock an “equal weight” rating in a research note on Friday, February 21st. Finally, Barclays boosted their price objective on shares of Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a research note on Thursday, November 21st. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $75.27.

Insider Activity at Ryan Specialty

In related news, Director Nicholas Dominic Cortezi sold 29,466 shares of the company’s stock in a transaction on Monday, January 13th. The shares were sold at an average price of $65.06, for a total value of $1,917,057.96. Following the sale, the director now directly owns 45,409 shares of the company’s stock, valued at $2,954,309.54. This represents a 39.35 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Brendan Martin Mulshine sold 30,000 shares of the company’s stock in a transaction on Friday, March 14th. The shares were sold at an average price of $69.30, for a total transaction of $2,079,000.00. The disclosure for this sale can be found here. Insiders have sold 276,451 shares of company stock valued at $18,293,293 over the last ninety days. Corporate insiders own 11.10% of the company’s stock.

Ryan Specialty Price Performance

Shares of RYAN stock opened at $71.33 on Tuesday. The company has a market capitalization of $18.68 billion, a PE ratio of 103.38, a price-to-earnings-growth ratio of 1.19 and a beta of 0.71. The firm has a fifty day simple moving average of $67.30 and a 200-day simple moving average of $67.81. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. Ryan Specialty Holdings, Inc. has a twelve month low of $48.48 and a twelve month high of $75.97.

Ryan Specialty (NYSE:RYAN) last announced its earnings results on Thursday, February 20th. The company reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.47 by ($0.02). The firm had revenue of $663.53 million during the quarter, compared to analysts’ expectations of $658.80 million. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. Equities research analysts anticipate that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current fiscal year.

Ryan Specialty Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Tuesday, March 4th will be paid a $0.12 dividend. The ex-dividend date is Tuesday, March 4th. This is an increase from Ryan Specialty’s previous quarterly dividend of $0.11. This represents a $0.48 annualized dividend and a dividend yield of 0.67%. Ryan Specialty’s dividend payout ratio is 69.57%.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.